- Filed
- Jul 31, 2023 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted restated | FY 2023 · Mar 31, 2023 | 7.87K sh |
| Shares Diluted restated | FY 2023 · Mar 31, 2022 | 8.78K sh |
| Shares Diluted restated | FY 2023 · Mar 31, 2021 | 9.16K sh |
| Stock Repurchased | FY 2023 · Mar 31, 2023 | $41.21M |
| Stock Repurchased | FY 2023 · Mar 31, 2022 | $38.79M |
| Stock Repurchased | FY 2023 · Mar 31, 2021 | $4.36M |
| Dividends Paid | FY 2023 · Mar 31, 2023 | $23K |
| Dividends Paid | FY 2023 · Mar 31, 2022 | $23K |
| Dividends Paid | FY 2023 · Mar 31, 2021 | $23K |
| Capex | FY 2023 · Mar 31, 2023 | $70.63M |
| Capex | FY 2023 · Mar 31, 2022 | $53.37M |
| Capex | FY 2023 · Mar 31, 2021 | $71.43M |
| Operating Cash Flow | FY 2023 · Mar 31, 2023 | −$212.8M |
| Operating Cash Flow | FY 2023 · Mar 31, 2022 | $30.15M |
| Operating Cash Flow | FY 2023 · Mar 31, 2021 | $183.18M |
| Long Term Debt | FY 2023 · Mar 31, 2023 | $432.7M |
| Long Term Debt | FY 2023 · Mar 31, 2022 | $109.62M |
| Short Term Debt | FY 2023 · Mar 31, 2023 | $10M |
| Short Term Debt | FY 2023 · Mar 31, 2022 | $4M |
| Cash And Equivalents restated | FY 2023 · Mar 31, 2023 | $12.26M |
| Cash And Equivalents | FY 2023 · Mar 31, 2022 | $10.9M |
| Stockholders Equity restated | FY 2023 · Mar 31, 2023 | $554.75M |
| Stockholders Equity restated | FY 2023 · Mar 31, 2022 | $579.03M |
| Current Liabilities restated | FY 2023 · Mar 31, 2023 | $156.19M |
| Current Liabilities | FY 2023 · Mar 31, 2022 | $173.16M |
| Total Liabilities restated | FY 2023 · Mar 31, 2023 | $657.97M |
| Total Liabilities restated | FY 2023 · Mar 31, 2022 | $363.24M |
| Current Assets restated | FY 2023 · Mar 31, 2023 | $794.04M |
| Current Assets restated | FY 2023 · Mar 31, 2022 | $550.69M |
| Total Assets restated | FY 2023 · Mar 31, 2023 | $1.21B |
| Total Assets restated | FY 2023 · Mar 31, 2022 | $942.27M |
| Eps Diluted restated | FY 2023 · Mar 31, 2023 | $1.16 |
| Eps Diluted restated | FY 2023 · Mar 31, 2022 | $5.24 |
| Eps Diluted | FY 2023 · Mar 31, 2021 | $13.72 |
| Eps Basic restated | FY 2023 · Mar 31, 2023 | $1.19 |
| Eps Basic restated | FY 2023 · Mar 31, 2022 | $5.28 |
| Eps Basic | FY 2023 · Mar 31, 2021 | $13.82 |
| Sga Expense | FY 2023 · Mar 31, 2023 | $81.07M |
| Sga Expense | FY 2023 · Mar 31, 2022 | $76.34M |
| Sga Expense | FY 2023 · Mar 31, 2021 | $79.95M |
| Net Income restated | FY 2023 · Mar 31, 2023 | $9.23M |
| Net Income restated | FY 2023 · Mar 31, 2022 | $46.2M |
| Net Income | FY 2023 · Mar 31, 2021 | $126.1M |
| Operating Income restated | FY 2023 · Mar 31, 2023 | $21.36M |
| Operating Income restated | FY 2023 · Mar 31, 2022 | $64.01M |
| Operating Income | FY 2023 · Mar 31, 2021 | $181.07M |
| Cost Of Revenue restated | FY 2023 · Mar 31, 2023 | $1.41B |
| Cost Of Revenue restated | FY 2023 · Mar 31, 2022 | $1.24B |
| Cost Of Revenue | FY 2023 · Mar 31, 2021 | $1.24B |